lyophilized tirzepatide (5mg/10mg/15mg/20mg/30mg) Bulk Tirzepatide-RUO 30MG x 10

metoclopramide Drug-specific interactions: Oxybutynin is metabolised by CYP3A4 Medicinal products that can cause or exacerbate oesophagitis such as bisphosphonates Caution with concomitant administration with CYP3A4 inhibitors, which can lead inhibit oxybutynin metabolism and therefore increase exposure to oxybutynin

The background risk of major birth defects in the general US population is approximately 2-4%, while the risk of miscarriage in clinically recognized pregnancies ranges from 15-20%, according to CDC data

GLP-1RA and DPP-4 inhibitors are useful in the management of patients with T2DM over the spectrum of HbA1c levels, including drug nave patients as well as those treated with other glucose lowering therapies

At the 8mg maintenance level, it becomes 4mg per injection

Many patients describe less preoccupation with food, fewer cravings, and less urgency around eating